Key result
4D-Flow MRI links HCM to ~74% higher flow-normalized early intraventricular pressure differences vs controls.
Why the study?
Noninvasive alternatives to transthoracic echocardiography are needed to overcome geometric and acoustic limitations when assessing LV diastolic dysfunction. This study evaluated 4D-Flow MRI-derived intraventricular pressure differences and flow propagation velocity in patients with hypertrophic cardiomyopathy.
Does 4D-Flow MRI-derived intraventricular pressure differences and flow propagation velocity differentiate left ventricular diastolic filling in patients with hypertrophic cardiomyopathy compared to healthy controls?
Case-Control (n=76)
Does 4D-Flow MRI-derived intraventricular pressure differences and flow propagation velocity differentiate left ventricular diastolic filling in patients with hypertrophic cardiomyopathy compared to healthy controls?
4D-Flow MRI-derived flow-normalized intraventricular pressure differences and propagation velocity serve as noninvasive markers of altered left ventricular chamber stiffness and impaired diastolic filling in hypertrophic cardiomyopathy.
HCM patients show faster VP on 4D-Flow MRI; hypothesis-generating for noninvasive diastolic assessment and requires prospective validation.
Background Transthoracic echocardiography (TTE) remains the gold standard for assessing left ventricular (LV) diastolic dysfunction (DD), but noninvasive alternatives are needed to overcome geometric and acoustic limitations. 4D-Flow MRI enables comprehensive assessment of intraventricular pressure differences (IVPDs) and flow propagation velocity (VP). We aimed to evaluate 4D-Flow-derived IVPDs and VP in patients with hypertrophic cardiomyopathy (HCM). Methods Thirty-eight HCM patients and 38 age- and sex-matched healthy controls underwent TTE and 4D-Flow MRI. Spatiotemporal maps of velocity and IVPDs, decomposed into inertial and convective components, were derived along the main inflow streamline from the mitral valve to the apex. Peak early filling rate (PEFR) was used to normalize IVPDs and VP. Results While absolute peak flow rates were comparable, HCM patients exhibited significantly faster VP (100.4 vs. 60.2 cm/s, p < 0.01) and higher positive early E IVPD (1.40 vs. 0.92 mmHg, p < 0.01) compared to controls. Normalizing IVPDs by PEFR amplified group differences, revealing a markedly increased flow-normalized E-IVPD (5.13 vs. 2.94 × 10⁻³ mmHg·ml⁻¹·s, p < 0.001) and deeper reverse ER IVPD (-6.06 vs. -4.61 × 10⁻³ mmHg·ml⁻¹·s, p < 0.01) in HCM. These differences were primarily driven by the inertial components. Multivariable analysis demonstrated that ER IVPD is independently determined by PEFR and the TTE E/E’ ratio (r = 0.65, p < 0.001). Conclusions 4D-Flow MRI-derived, flow-normalized IVPDs and propagation velocity provide robust, noninvasive markers of altered LV chamber stiffness and impaired diastolic filling in HCM, offering deeper 3D hemodynamic insights into diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Stipechi et al. (2026) conducted a case-control in Hypertrophic cardiomyopathy (n=76). 4D-Flow MRI vs. Age- and sex-matched healthy controls was evaluated on 4D-Flow MRI-derived flow-normalized early E intraventricular pressure difference (E-IVPD) (p=<0.001). 4D-Flow MRI showed faster propagation velocity (100.4 vs 60.2 cm/s, p<0.01) and higher flow-normalized E-IVPD (5.13 vs 2.94 ×10⁻³ mmHg·ml⁻¹·s, p<0.001) in HCM vs controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: